Primary Neuroendocrine Breast Carcinoma (NEBC): A Case Report
Published: 2024-07-06
Page: 360-366
Issue: 2024 - Volume 7 [Issue 2]
Rangra Gayatri
Department of Surgery, ASMC Kaushambi, India.
Singhal Basant Mohan *
Department of Surgical Oncology, M L N Medical College, Prayagraj, India.
Kewlani Vishal
Department of Surgery, M L N Medical College, Prayagraj, India.
Yadav Dev Kumar
Department of Radiation Oncology, M L N Medical College, Prayagraj, India.
*Author to whom correspondence should be addressed.
Abstract
Primary Neuroendocrine Breast Carcinoma (NEBC) is a rare tumor with an incident rate of <0.1% of Breast Cancers and <1% of all neuroendocrine neoplasms. This case report describes a 60-year-old female patient with NEBC of the left breast with no axillary lymphadenopathy or metastasis at initial presentation. The tumor cells were positive for neuroendocrine markers, a highKi67 proliferation index and negative for ER/PR and Her2neu. Breast neuroendocrine tumors are a rare heterogenous group of tumors and further studies are needed to understand its’ presentation and establish effective management strategies.
Keywords: Neuroendocrine neoplasms, neuroendocrine carcinoma, breast cancer, NEBC, NECB
How to Cite
References
Mohamed A, Zeidalkilani J, Asa SL, Trybula M, Montero AJ. Management of neuroendocrine breast carcinoma (NEBC): Review of literature. Oncol Rev. 2024; 18:12114. Published 2024 Feb 9.DOI: 10.3389/or.2024.12114
WHO Classification of Tumours. Breast Tumours. 5th Edition. Lyon, France: IARC; 2019.
Chai Y, Liu M, Li Z, Chen Y, Qi F, Li Q, Xu B. Retrospective literature review of primary neuroendocrine neoplasms of the breast (BNEN) in 209 Chinese patients: Treatment and prognostic factor analysis. The Breast. 2022 Apr 1;62:93-102.
Tavassoli FA, Devilee P, Eds. World health organization classfication of tumors. Pathology & genetics of tumours of the breast and female genital organs. IARC (International Agency for Research on Cancer) Press, Lyon. 2003;153-158.
Trevisi E, La Salvia A, Daniele L, Brizzi MP, De Rosa G, Scagliotti GV, et al. Neuroendocrine breast carcinoma: A rare but challenging entity. Med Oncol. 2020;37(8):70.DOI: 10.1007/s12032-020-01396-4
Marinova L, Malinova D, Vicheva S. Primary neuroendocrine carcinoma of the breast: histopathological criteria, prognostic factors, and review of the literature. Case Rep Pathol. 2016;2016: 6762085.DOI: 10.1155/2016/6762085
Ozaki Y, Miura S, Oki R, Morikawa T, Uchino K. Neuroendocrine neoplasms of the breast: The latest WHO classification and review of the literature. Cancers (Basel). 2021;14(1):196. Published 2021 Dec 31.DOI: 10.3390/cancers14010196
Gallo M, Campione S, Di Vito V, et al. Primary neuroendocrine neoplasms of the breast: Still open issues. Front Endocrinol (Lausanne). 2021;11:610230. Published 2021 Jan 26.DOI: 10.3389/fendo.2020.610230
Wang J, Wei B, Albarracin CT, Hu J, Abraham SC, Wu Y. Invasive neuroendocrine carcinoma of the breast: A population-based study from the surveillance, epidemiology and end results (SEER) database. BMC Cancer. 2014;14:147. Published 2014 Mar 4.DOI: 10.1186/1471-2407-14-147
Ogawa H, Nishio A, Satake H, Naganawa S, Imai T, Sawaki M, et al. Neuroendocrine tumor in the breast. Radiat Med (2008) 26(1):28–32.DOI: 10.1007/s11604-007-0182-y
Sun H, Dai S, Xu J, Liu L, Yu J, Sun T. Primary neuroendocrine tumor of the breast: Current understanding and future perspectives. Front Oncol. 2022;12:848485. Published 2022 May 25.DOI: 10.3389/fonc.2022.848485
El Arab KF, Bourhafour M, Elqasseh R, et al. Primary neuroendocrine tumors of the breast: About a case and of the review of the literature. Int J Surg Case Rep. 2022;99:107642.DOI: 10.1016/j.ijscr.2022.107642
Irelli A, Sirufo MM, Morelli L, D'Ugo C, Ginaldi L, De Martinis M. Neuroendocrine cancer of the breast: A rare entity. J Clin Med. 2020;9(5):1452. Published 2020 May 13.DOI: 10.3390/jcm9051452
Arnason, Thomas & Sapp, Heidi & Barnes, Penny & Drewniak, Magdalena & Abdolell, Mohamed & Rayson, Daniel. Immunohistochemical expression and prognostic value of ER, PR and HER2/neu in Pancreatic and Small Intestinal Neuroendocrine Tumors. Neuroendocrinology. 2011;93:249-58.DOI: 10.1159/000326820
Richter-Ehrenstein C, Arndt J, Buckendahl AC, et al. Solid neuroendocrine carcinomas of the breast: metastases or primary tumors?. Breast Cancer Res Treat. 2010;124(2):413-417.DOI: 10.1007/s10549-010-1178-3
Hare F, Giri S, Patel JK, Hahn A, Martin MG. A population-based analysis of outcomes for small cell carcinoma of the breast by tumor stage and the use of radiation therapy. Springerplus 2015;4:138.
Wei B, Ding T, Xing Y, Wei W, Tian Z, Tang F, Abraham S, Nayeemuddin K, Hunt K, Wu Y. Invasive neuroendocrine carcinoma of the breast: A distinctive subtype of aggressive mammary carcinoma. Cancer 2010;116: 4463–4473.
Yang L, Roy M, Lin H, et al. Validation of prognostic significance of the proposed uniform classification framework in neuroendocrine neoplasms of the breast. Breast Cancer Res Treat. 2021;186(2): 403-415.DOI: 10.1007/s10549-021-06099-6